PURPOSE: The ketogenic diet (KD) is an effective treatment for intractable epilepsy (IE), however the therapeutic mechanism is still unclear. This study was designed to investigate T helper type 17/regulatory T cell (Th17/Treg) levels in children with IE and age-matched healthy controls following KD. METHOD: Circulating levels of Th17/Treg cells were analyzed by flow cytometry. Plasma concentration of interleukin (IL)-17 was measured by cytometric bead array assay. Real-time PCR was performed to measure mRNA levels of mTOR, HIF1α and Th17/Treg associated factors in purified CD4(+)CD25(+) T and CD4(+)CD25(-) T cells. RESULTS: By one-way ANOVA, the proportion of circulating Th17 cells and expression of IL-17A and RORγt were significantly higher (P<.05), while the proportion of circulating Tregs and expression of Foxp3, GITR, CTLA-4 were significantly lower (P<.05) in IE patients than healthy subjects. However, these alternations were reversed following KD (P<.05). In CD4(+)CD25(+) T and CD4(+)CD25(-) T cells mTOR and HIF1α expression were significantly higher in IE patients (P<.05), however KD reduced mTOR and HIF1α expression (P<.05). The plasma IL-17A concentrations were higher in IE patients than controls (P<.05). KD partially reduced IL-17A levels (P<.05). CONCLUSION: Our results suggest that Th17/Treg imbalance is characteristic of childhood IE, and may contribute to IE pathogenesis. KD treatment is able to correct this imbalance, probably via inhabiting the mTOR/HIF-1α signaling pathway.
PURPOSE: The ketogenic diet (KD) is an effective treatment for intractable epilepsy (IE), however the therapeutic mechanism is still unclear. This study was designed to investigate T helper type 17/regulatory T cell (Th17/Treg) levels in children with IE and age-matched healthy controls following KD. METHOD: Circulating levels of Th17/Treg cells were analyzed by flow cytometry. Plasma concentration of interleukin (IL)-17 was measured by cytometric bead array assay. Real-time PCR was performed to measure mRNA levels of mTOR, HIF1α and Th17/Treg associated factors in purified CD4(+)CD25(+) T and CD4(+)CD25(-) T cells. RESULTS: By one-way ANOVA, the proportion of circulating Th17 cells and expression of IL-17A and RORγt were significantly higher (P<.05), while the proportion of circulating Tregs and expression of Foxp3, GITR, CTLA-4 were significantly lower (P<.05) in IE patients than healthy subjects. However, these alternations were reversed following KD (P<.05). In CD4(+)CD25(+) T and CD4(+)CD25(-) T cells mTOR and HIF1α expression were significantly higher in IE patients (P<.05), however KD reduced mTOR and HIF1α expression (P<.05). The plasma IL-17A concentrations were higher in IE patients than controls (P<.05). KD partially reduced IL-17A levels (P<.05). CONCLUSION: Our results suggest that Th17/Treg imbalance is characteristic of childhood IE, and may contribute to IE pathogenesis. KD treatment is able to correct this imbalance, probably via inhabiting the mTOR/HIF-1α signaling pathway.
Authors: Mathis Wolter; Erica T Grant; Marie Boudaud; Alex Steimle; Gabriel V Pereira; Eric C Martens; Mahesh S Desai Journal: Nat Rev Gastroenterol Hepatol Date: 2021-09-27 Impact factor: 46.802
Authors: Dan Xu; Andrew P Robinson; Toshiyuki Ishii; D'Anne S Duncan; Tord D Alden; Gwendolyn E Goings; Igal Ifergan; Joseph R Podojil; Pablo Penaloza-MacMaster; Jennifer A Kearney; Geoffrey T Swanson; Stephen D Miller; Sookyong Koh Journal: J Exp Med Date: 2018-02-27 Impact factor: 14.307
Authors: J Nicholas Brenton; Brenda Banwell; A G Christina Bergqvist; Diana Lehner-Gulotta; Lauren Gampper; Emily Leytham; Rachael Coleman; Myla D Goldman Journal: Neurol Neuroimmunol Neuroinflamm Date: 2019-04-12
Authors: David Licha; Silvia Vidali; Sepideh Aminzadeh-Gohari; Oliver Alka; Leander Breitkreuz; Oliver Kohlbacher; Roland J Reischl; René G Feichtinger; Barbara Kofler; Christian G Huber Journal: Int J Mol Sci Date: 2019-08-08 Impact factor: 5.923
Authors: Qi Yan Ang; Margaret Alexander; John C Newman; Yuan Tian; Jingwei Cai; Vaibhav Upadhyay; Jessie A Turnbaugh; Eric Verdin; Kevin D Hall; Rudolph L Leibel; Eric Ravussin; Michael Rosenbaum; Andrew D Patterson; Peter J Turnbaugh Journal: Cell Date: 2020-05-20 Impact factor: 41.582
Authors: Brianna J Stubbs; Andrew P Koutnik; Emily L Goldberg; Vaibhav Upadhyay; Peter J Turnbaugh; Eric Verdin; John C Newman Journal: Med (N Y) Date: 2020-07-15
Authors: Patrick C Bradshaw; William A Seeds; Alexandra C Miller; Vikrant R Mahajan; William M Curtis Journal: Oxid Med Cell Longev Date: 2020-09-09 Impact factor: 6.543